BOUL Boule Diagnostics AB (publ)
2.340SEK-2.90%Mkt Cap: 8.69M $P/E: —1d ago
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and …
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap8.69M USD
Enterprise Value28.82M USD
Revenue (TTM)44.12M USD
Gross Profit20.45M USD
Net Income (TTM)-358.98K USD
Revenue/Share13.01 SEK
Last Price2.340 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees200
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)2.13
PEG—
EV/EBITDA13.91
EV/Revenue0.65
P/S0.20
P/B0.54
EPS (TTM)-0.10
EPS (Forward)1.13
52W Range
2.2103% of range6.640
52W High6.640 SEK
52W Low2.210 SEK
Profitability
Gross Margin43.66%
Oper. Margin2.94%
EBITDA Margin4.69%
Profit Margin-0.77%
ROE-2.24%
ROA-0.80%
Growth
Revenue Growth-13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF79.30K USD
CapEx (TTM)474.72K USD
FCF Margin0.21%
FCF Yield1.09%
Net Debt19.87M USD
Net Debt/EBITDA9.59
Balance Sheet
Debt/Equity1.33
Current Ratio1.07
Quick Ratio0.68
Book Value/Sh4.50 SEK
Cash/Share0.51 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateMay 6, 2022
Pay Date—
Splits
Last Split4:1
Split DateJun 1, 2018
Analyst Consensus
Rating—
Target (Mean)3.800 SEK
Upside (mean)+62.4%
Target Range3.800 SEK – 3.800 SEK
# Analysts1
Ownership
Shares Out.38.83M
Float22.80M
Insiders35.31%
Institutions49.20%
Technical
SMA 503.070 (-23.8%)
SMA 2003.807 (-38.5%)
Beta0.17
S&P 52W Chg14.58%
Avg Vol (30d)46.42K
Avg Vol (10d)31.35K
Technical Indicators
RSI (14)36.8
MACD-0.2158
MACD Signal-0.2310
MACD Hist.+0.0152
BB Upper2.972 SEK
BB Middle2.517 SEK
BB Lower2.061 SEK
BB Width36.22%
ATR (14)0.1766 SEK
Vol Ratio (20d)0.22x